+

WO1999033867A3 - Analogues d'acide nucleique modifies - Google Patents

Analogues d'acide nucleique modifies Download PDF

Info

Publication number
WO1999033867A3
WO1999033867A3 PCT/EP1998/008317 EP9808317W WO9933867A3 WO 1999033867 A3 WO1999033867 A3 WO 1999033867A3 EP 9808317 W EP9808317 W EP 9808317W WO 9933867 A3 WO9933867 A3 WO 9933867A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligomers
nucleic acid
modified nucleic
acid analogues
low
Prior art date
Application number
PCT/EP1998/008317
Other languages
German (de)
English (en)
Other versions
WO1999033867A2 (fr
Inventor
Frank Bergmann
Der Eltz Herbert Von
Rupert Herrmann
Stefanie Koehler
Volker Schlueter
Original Assignee
Roche Diagnostics Gmbh
Frank Bergmann
Der Eltz Herbert Von
Rupert Herrmann
Stefanie Koehler
Volker Schlueter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh, Frank Bergmann, Der Eltz Herbert Von, Rupert Herrmann, Stefanie Koehler, Volker Schlueter filed Critical Roche Diagnostics Gmbh
Priority to EP98966833A priority Critical patent/EP0996631A1/fr
Publication of WO1999033867A2 publication Critical patent/WO1999033867A2/fr
Publication of WO1999033867A3 publication Critical patent/WO1999033867A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6832—Enhancement of hybridisation reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Des oligomères comportant au moins une unité non nucléoside qui contient une fonction acide avec un pKa inférieur à 3,0, s'utilisent notamment comme sondes de mise en évidence de la présence d'acides nucléiques, les interactions non spécifiques étant abaissées comparativement à des oligomères non modifiés. Même à de faibles concentrations en sel du tampon d'hybridation, on peut obtenir une dynamique du signal et une sensibilité élevées en cas de signal réduit d'essai à blanc. Ces oligomères s'utilisent également comme amorces pour des réactions d'allongement à l'aide de polymérases et pour des opérations de transfection.
PCT/EP1998/008317 1997-12-23 1998-12-18 Analogues d'acide nucleique modifies WO1999033867A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP98966833A EP0996631A1 (fr) 1997-12-23 1998-12-18 Analogues d'acide nucleique modifies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757516.1 1997-12-23
DE19757516A DE19757516A1 (de) 1997-12-23 1997-12-23 Modifizierte Nukleinsäureanaloga

Publications (2)

Publication Number Publication Date
WO1999033867A2 WO1999033867A2 (fr) 1999-07-08
WO1999033867A3 true WO1999033867A3 (fr) 1999-09-02

Family

ID=7853170

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/008317 WO1999033867A2 (fr) 1997-12-23 1998-12-18 Analogues d'acide nucleique modifies

Country Status (3)

Country Link
EP (1) EP0996631A1 (fr)
DE (1) DE19757516A1 (fr)
WO (1) WO1999033867A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019135A1 (de) 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
DE10019136A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
EP1251183A3 (fr) * 2001-04-18 2003-12-10 Exiqon A/S Des sondes assistantes supérieures pour la détéction d'une séquence cible utilisant une sonde de capture

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284208A (en) * 1993-11-25 1995-05-31 Pna Diagnostics As Nucleic acid analogues with a chelating functionality for metal ions
WO1996011205A1 (fr) * 1994-10-06 1996-04-18 Isis Pharmaceuticals, Inc. Conjugues d'acides nucleiques peptidiques
WO1996035705A1 (fr) * 1995-05-10 1996-11-14 Isis Pharmaceuticals, Inc. Inhibition, au moyen d'une invasion de brins oligomeres, de l'activation par transcription induite par un facteur de transcription

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284208A (en) * 1993-11-25 1995-05-31 Pna Diagnostics As Nucleic acid analogues with a chelating functionality for metal ions
WO1996011205A1 (fr) * 1994-10-06 1996-04-18 Isis Pharmaceuticals, Inc. Conjugues d'acides nucleiques peptidiques
WO1996035705A1 (fr) * 1995-05-10 1996-11-14 Isis Pharmaceuticals, Inc. Inhibition, au moyen d'une invasion de brins oligomeres, de l'activation par transcription induite par un facteur de transcription

Also Published As

Publication number Publication date
DE19757516A1 (de) 1999-06-24
EP0996631A1 (fr) 2000-05-03
WO1999033867A2 (fr) 1999-07-08

Similar Documents

Publication Publication Date Title
AU7000791A (en) Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions
AU1250799A (en) Pcr primer constructs for use in an integrated signalling system
CA2145576A1 (fr) Detection de l'amplification de l'acide nucleique
WO2001079563A3 (fr) Sondes d'acides nucleiques degradables et methodes de detection d'acides nucleiques
WO1999049082A3 (fr) Nucleotides modifies et methodes utiles pour le sequençage d'acides nucleiques
EP1034302A4 (fr) Matrice de sequen age de novo ou "universelle"
CA2332518A1 (fr) Generation de produits d'amplification de l'acide nucleique par utilisation de concentrations inegales d'amorces
EP0823479A3 (fr) Polymérase d'ADN thermostable modifiée
AU6710987A (en) Detection of viruses by amplification and hybridization
WO2005100602A3 (fr) Biocapteurs bases sur un assemblage dirige de particules
CA2272273A1 (fr) Methodes, appareils et programmes informatiques pour determiner les quantites de sequences nucleotidiques dans des echantillons au moyen de courbes d'etalonnage et d'estimations des ratios d'amplification standard
FI953445A0 (fi) Menetelmä nukleiinihappojen herkkään osoitukseen
AU6846698A (en) Method of nucleic acid amplification
WO1999005315A3 (fr) Analyse de sequences nucleotidiques
EP0269445A3 (fr) Procédé de détection des virus HTLVI et HTLVII par hybridation
CA2311952A1 (fr) Systeme fluorometrique de detection d'un acide nucleique
AU2001245945A1 (en) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
EP0393743A3 (fr) Kit diagnostique, composition d'amorce et leur utilisation pour la réplication ou la détection d'acides nucléiques
WO1999041273A3 (fr) Conjugues d'anp et d'adn et procedes de preparation desdits conjugues
WO2000024931A3 (fr) Detection d'analytes
WO2003008638A3 (fr) Tri et immobilisation de systeme pour systemes de liaison synthetique d'acides nucleiques
EP0915174A4 (fr) Procede de detection de sequences nucleotidiques cibles
EP0803578A3 (fr) Coffret pour l'amplification et la détection des acides nucléiques du cytomegalovirus (CMV) utilisant une séquence d'acide nucléique ss2.7
WO1997032040A3 (fr) Detection d'une sequence d'acide nucleique
WO1999033867A3 (fr) Analogues d'acide nucleique modifies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998966833

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998966833

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1998966833

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载